King Loses Injunction Bid In Skelaxin Suit V. Sandoz

Law360, New York (May 19, 2010, 5:13 PM EDT) -- A federal judge has shot down a bid by King Pharmaceuticals Inc. to block Novartis AG generics unit Sandoz Inc. from making its own version of muscle relaxant Skelaxin.

Judge Garrett E. Brown Jr. of the U.S. District Court for the District of New Jersey ruled Monday that King hadn't shown that it was likely to succeed on the merits of the suit, or that it would suffer irreparable harm in the absence of a preliminary injunction.

The suit, filed in December 2008, accuses Sandoz of...
To view the full article, register now.